This MedLibrary.org supplementary page on Valerenic acid is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Valerenic acid | |
|---|---|
 |
|
 |
|
| IUPAC name | (E)-3-[(4S,7R,7aR)-3,7-dimethyl- 2,4,5,6,7,7a-hexahydro- 1H-inden-4-yl]- 2-methylprop-2-enoic acid |
| Identifiers | |
| CAS number | [3569-10-6] |
| PubChem | |
| SMILES |
|
| Properties | |
| Molecular formula | C15H22O2 |
| Molar mass | 234.334 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox references |
|
Valerenic acid is a constituent of the essential oil of the Valerian plant.
Valerian is used as a herbal sedative which may be helpful in the treatment of insomnia. While the precise mechanism of this action has not been established and it is likely that several different components of the plant contribute to the effect, valerenic acid is thought to be at least partly responsible for the sedative effects.
Valerenic acid has been demonstrated to be both a subtype-selective GABAA agonist[1] acting mainly at α1β2 and α1β3 subtypes,[2] and also a 5HT5A partial agonist.[3] Both of these actions are likely to play a role in the sedative effects of this compound, as other GABAA agonists such as benzodiazepines are commonly used as sedative drugs, and while no selective 5HT5A agonists are currently used medically, the 5HT5A receptor is known to be highly expressed in the suprachiasmatic nucleus of the brain, which is believed to be involved in the sleep-wake cycle.
Valerenic acid has also been reported to be an NF-κB inhibitor, and may be partly responsible for the reported anti-inflammatory action of the valerian plant.[4]
References
- ^ Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, Ang-Lee MK. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesthesia and Analgesia. 2004 Feb;98(2):353-8.
- ^ Khom S, Baburin I, Timin E, Hohaus A, Trauner G, Kopp B, Hering S. Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology. 2007 Jul;53(1):178-87.
- ^ Dietz BM, Mahady GB, Pauli GF, Farnsworth NR. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Research. Molecular Brain Research. 2005 Aug 18;138(2):191-7.
- ^ Jacobo-Herrera NJ, Vartiainen N, Bremner P, Gibbons S, Koistinaho J, Heinrich M. NF-kappaB modulators from Valeriana officinalis. Phytotherapy Research. 2006 Oct;20(10):917-9.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 11 April 2008, at 22:48.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Valerenic acid".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.